← Health care and life sciences companies

    Acuitas Therapeutics: company profile, size and contacts

    acuitastx.comActiveFor profit

    Acuitas provides delivery solutions for molecular therapeutics using lipid nanoparticles (LNP).

    Employees
    11-50
    Founded
    2009
    Monthly visits
    930
    Traffic rank
    #7,017,174

    Company facts

    Website
    acuitastx.com
    Employees
    11-50
    Founded
    2009 (17 years ago)
    Categories
    Biotechnology, Nanotechnology
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Thomas MaddenFounder · Acuitas Therapeutics

    Acuitas Therapeutics was founded in 2009 by Thomas Madden.

    Web and app presence

    Monthly website visits
    930
    Global traffic rank
    #7,017,174

    How Acuitas Therapeutics compares

    • Size: Acuitas Therapeutics has more employees than 15% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: Acuitas Therapeutics is older than 41% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: Acuitas Therapeutics gets more monthly website visits than 29% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range.

    Growth outlook

    • Trend: Growing

    Acuitas Therapeutics may be growing as evidenced by its recent settlement of a lawsuit over COVID-19 vaccine patent rights, which could indicate a resolution of disputes that may have previously hindered its operations. Additionally, the company has entered into a strategic partnership with Aldevron, which could potentially expand its operational capabilities and market reach. Furthermore, the global market for lipid nanoparticle raw materials, which are relevant to Acuitas Therapeutics' field of operation, is projected to grow, suggesting a favorable market environment for the company's services.

    What Acuitas Therapeutics says about itself

    “Acuitas is the global leader in the development of lipid nanoparticle delivery systems. Learn more about the real world applications of our unmatched LNP platform.” acuitastx.com

    Acuitas Therapeutics in short

    Acuitas Therapeutics is a biotechnology company, with 11-50 employees, founded in 2009. Its website drew about 930 visits in the latest month measured and its founder is Thomas Madden.

    Frequently asked questions

    What does Acuitas Therapeutics do?
    Acuitas provides delivery solutions for molecular therapeutics using lipid nanoparticles (LNP).
    When was Acuitas Therapeutics founded?
    Acuitas Therapeutics was founded in 2009, so it is about 17 years old.
    How many employees does Acuitas Therapeutics have?
    Crunchbase lists Acuitas Therapeutics in the 11-50 employee range.
    Has Acuitas Therapeutics raised funding?
    Crunchbase has no funding rounds on record for Acuitas Therapeutics.
    How do I find email addresses at Acuitas Therapeutics?
    Search the domain acuitastx.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.